{"id":477,"date":"2026-08-28T06:56:06","date_gmt":"2026-08-28T06:56:06","guid":{"rendered":"https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/"},"modified":"2026-08-28T07:31:46","modified_gmt":"2026-08-28T07:31:46","slug":"aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/de\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/","title":{"rendered":"AOD-9604-Beweisgrenze: GH-Fragmentbiologie, fehlgeschlagene Entwicklung und Chargenidentit\u00e4t"},"content":{"rendered":"<p class=\"pim-standfirst wp-block-paragraph\">AOD-9604 ist ein modifiziertes Wachstumshormonfragment, das auf der Grundlage einer Lipolyse-Hypothese entwickelt wurde. Pr\u00e4klinische Plausibilit\u00e4t und fr\u00fche Entwicklung haben keinen Vorrang vor der gr\u00f6\u00dferen Null-Adipositas-Studie.<\/p><div class=\"wp-block-group pim-key-takeaways\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><h2 class=\"wp-block-heading\">Was die Aufzeichnung zeigt<\/h2><ul class=\"wp-block-list\"><li>Die Wirksamkeitsbilanz beim Menschen ist schw\u00e4cher, als viele Produktzusammenfassungen vermuten lassen.<\/li><li>ClinicalTrials.gov enthielt in der 2024-Suche von FDA keine AOD-9604-Studien.<\/li><li>Sequenz-\/Formidentit\u00e4ts- und Chargentests k\u00f6nnen keinen therapeutischen Effekt nachweisen.<\/li><\/ul><\/div><\/div><figure class=\"wp-block-image size-full pim-article-figure\"><img loading=\"lazy\" decoding=\"async\" width=\"1536\" height=\"1024\" src=\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828.png\" alt=\"Wissenschaftler \u00fcberpr\u00fcft Forschungsdaten zu pulsierendem Wachstumshormon und IGF-1\" class=\"wp-image-459\" srcset=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828.png 1536w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828-300x200.png 300w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828-1024x683.png 1024w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828-768x512.png 768w\" sizes=\"auto, (max-width: 1536px) 100vw, 1536px\" \/><figcaption class=\"wp-element-caption\">Originale redaktionelle Illustration zur Identifizierung des Forschungsthemas. Es stellt keine Katalogcharge, kein zugelassenes Medikament, kein Testergebnis oder keine klinische Verwendung dar.<\/figcaption><\/figure><h2 class=\"wp-block-heading\">Die Identit\u00e4ts- und Beweisgrenze<\/h2><p class=\"wp-block-paragraph\">Auf einer Materialseite k\u00f6nnen Sequenzidentit\u00e4t, Analysemethoden und die historische Forschungshypothese genau er\u00f6rtert werden. Es sollte auch das Null-Entwicklungsergebnis in der N\u00e4he jeglicher Erw\u00e4hnung von Gewichtsverlustforschung ans Licht bringen.<\/p><div class=\"wp-block-group pim-evidence-table\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><div class=\"pim-evidence-row\"><strong>Mechanistischer Ursprung<\/strong><span>Modifiziertes GH-Fragment, untersucht in Stoffwechselmodellen<\/span><\/div><div class=\"pim-evidence-row\"><strong>Problem mit menschlichen Beweisen<\/strong><span>Wichtige gro\u00dfe Studie null und nicht vollst\u00e4ndig in einer Zeitschrift ver\u00f6ffentlicht<\/span><\/div><div class=\"pim-evidence-row\"><strong>Anspruchsgrenze<\/strong><span>Keine nachgewiesene klinische Wirksamkeit zur Gewichtsabnahme<\/span><\/div><\/div><\/div><h2 class=\"wp-block-heading\">Was in die Materialakte geh\u00f6rt<\/h2><p class=\"wp-block-paragraph\">Best\u00e4tigen Sie zur Chargen\u00fcberpr\u00fcfung die Sequenz, die Molek\u00fclform, die Masse, die Reinheitsmethode, den quantitativen Peptidgehalt und die Chargenverkn\u00fcpfung. Diese Kontrollen bestimmen die Materialcharakterisierung, nicht die klinische Wirksamkeit.<\/p><h2 class=\"wp-block-heading\">Redaktionelle Regel<\/h2><p class=\"wp-block-paragraph\">Verwenden Sie den genauen Interventionsnamen, das Modell, die Population und den Endpunkt aus dem zitierten Datensatz. Wandeln Sie eine Assoziation, einen Mechanismus, ein Tierergebnis, eine genehmigte Fertigarzneimittelaufzeichnung oder einen analytischen Test nicht in einen Anspruch \u00fcber eine nicht verwandte Katalogcharge um.<\/p>","protected":false},"excerpt":{"rendered":"<p>AOD-9604 ist ein modifiziertes Wachstumshormonfragment, das auf der Grundlage einer Lipolyse-Hypothese entwickelt wurde. Pr\u00e4klinische Plausibilit\u00e4t und fr\u00fche Entwicklung haben keinen Vorrang vor der gr\u00f6\u00dferen Null-Adipositas-Studie.<\/p>","protected":false},"author":1,"featured_media":642,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"314","pim_article_type":"Evidence and material-quality guide","pim_evidence_level":"Preclinical mechanism, incomplete clinical publication and FDA review","pim_reviewer":"NHD evidence editorial workflow","pim_reviewed_date":"2026-08-28","pim_editorial_note":"Source-checked on 2026-08-28. Null findings and study limitations are retained. This is not independent peer review, medical advice, a customer case, or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"At least two linked primary or authoritative records and an explicit evidence boundary are present.","pim_creation_method":"The editorial workflow starts with linked peer-reviewed papers, trial registries or regulatory records; extracts the population or model, endpoints, numerical results and limitations; and separates the studied intervention from catalog material. AI-assisted drafting was used to structure the first version. Claims, figures, evidence labels and limitations were checked against the linked records in the site editorial workflow. This is not independent peer review.","pim_sources":"[{\"title\":\"FDA December 2024 AOD-9604 briefing document\",\"url\":\"https:\/\/www.fda.gov\/media\/183584\/download\",\"note\":\"FDA review of effectiveness, safety and the OPTIONS result.\"},{\"title\":\"AOD-9604 development review\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15134286\/\",\"note\":\"Contemporaneous development summary; PMID 15134286.\"},{\"title\":\"FDA December 2024 PCAC meeting record\",\"url\":\"https:\/\/www.fda.gov\/advisory-committees\/advisory-committee-calendar\/updated-meeting-time-and-public-participation-information-december-4-2024-meeting-pharmacy\",\"note\":\"Regulatory meeting context.\"}]","footnotes":""},"categories":[20],"tags":[],"class_list":["post-477","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-evidence-quality-guides"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>AOD-9604 Evidence, Development &amp; Quality Boundaries<\/title>\n<meta name=\"description\" content=\"AOD-9604 is a modified growth-hormone fragment developed around a lipolysis hypothesis. Preclinical plausibility and early development do not override the\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/de\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AOD-9604 Evidence Boundary: GH Fragment Biology, Failed Development and Lot Identity\" \/>\n<meta property=\"og:description\" content=\"AOD-9604 is a modified growth-hormone fragment developed around a lipolysis hypothesis. Preclinical plausibility and early development do not override the\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/de\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-28T06:56:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-28T07:31:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary-featured-v2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"AOD-9604 Evidence Boundary: GH Fragment Biology, Failed Development and Lot Identity\",\"datePublished\":\"2026-08-28T06:56:06+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\\\/\"},\"wordCount\":227,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary-featured-v2.webp\",\"articleSection\":[\"Evidence &amp; Quality Guides\"],\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\\\/\",\"name\":\"AOD-9604 Evidence, Development & Quality Boundaries\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary-featured-v2.webp\",\"datePublished\":\"2026-08-28T06:56:06+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"description\":\"AOD-9604 is a modified growth-hormone fragment developed around a lipolysis hypothesis. Preclinical plausibility and early development do not override the\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary-featured-v2.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary-featured-v2.webp\",\"width\":1536,\"height\":960,\"caption\":\"Article-specific editorial image.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AOD-9604 Evidence Boundary: GH Fragment Biology, Failed Development and Lot Identity\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/de\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"AOD-9604 Evidenz, Entwicklung und Qualit\u00e4tsgrenzen","description":"AOD-9604 ist ein modifiziertes Wachstumshormonfragment, das auf der Grundlage einer Lipolyse-Hypothese entwickelt wurde. Pr\u00e4klinische Plausibilit\u00e4t und fr\u00fche Entwicklung haben keinen Vorrang vor\u2026","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/de\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/","og_locale":"de_DE","og_type":"article","og_title":"AOD-9604 Evidence Boundary: GH Fragment Biology, Failed Development and Lot Identity","og_description":"AOD-9604 is a modified growth-hormone fragment developed around a lipolysis hypothesis. Preclinical plausibility and early development do not override the\u2026","og_url":"https:\/\/nhdbio.com\/de\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/","og_site_name":"NHD","article_published_time":"2026-08-28T06:56:06+00:00","article_modified_time":"2026-08-28T07:31:46+00:00","og_image":[{"width":1536,"height":960,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary-featured-v2.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Verfasst von":"NHD Technical Team","Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"AOD-9604 Evidence Boundary: GH Fragment Biology, Failed Development and Lot Identity","datePublished":"2026-08-28T06:56:06+00:00","dateModified":"2026-08-28T07:31:46+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/"},"wordCount":227,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary-featured-v2.webp","articleSection":["Evidence &amp; Quality Guides"],"inLanguage":"de","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/","url":"https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/","name":"AOD-9604 Evidenz, Entwicklung und Qualit\u00e4tsgrenzen","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary-featured-v2.webp","datePublished":"2026-08-28T06:56:06+00:00","dateModified":"2026-08-28T07:31:46+00:00","description":"AOD-9604 ist ein modifiziertes Wachstumshormonfragment, das auf der Grundlage einer Lipolyse-Hypothese entwickelt wurde. Pr\u00e4klinische Plausibilit\u00e4t und fr\u00fche Entwicklung haben keinen Vorrang vor\u2026","breadcrumb":{"@id":"https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary-featured-v2.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary-featured-v2.webp","width":1536,"height":960,"caption":"Article-specific editorial image."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/aod-9604-gh-fragment-evidence-regulatory-and-quality-boundary\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"AOD-9604 Evidence Boundary: GH Fragment Biology, Failed Development and Lot Identity"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Peptidrohstoffe und individuelle Peptidsynthese","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"NHD Technisches Team","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"Das technische Team von NHD verwaltet Katalogdokumentationen und Beweiszusammenfassungen f\u00fcr Forschungszwecke. Rezensierte Artikel verweisen auf von Experten begutachtete Artikel, Studienregister und beh\u00f6rdliche Aufzeichnungen, behalten Nullergebnisse und Studieneinschr\u00e4nkungen bei und unterscheiden ver\u00f6ffentlichte Interventionen von Katalogmaterialien. F\u00fcr die Strukturierung kann AI-unterst\u00fctztes Zeichnen verwendet werden; Quellenverkn\u00fcpfungen und Beweisgrenzen bleiben sichtbar. Bei dieser Arbeit handelt es sich nicht um eine unabh\u00e4ngige Begutachtung oder medizinische Beratung.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/de\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/477","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/comments?post=477"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/477\/revisions"}],"predecessor-version":[{"id":499,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/477\/revisions\/499"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/media\/642"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/media?parent=477"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/categories?post=477"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/tags?post=477"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}